Back
Can Fite Biofarma Vs. ResMed Industry Stock Comparison
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.02
Seasonality Move:
0.68%
Sell
37
RMD
ResMed
Last Price:
238.89
Seasonality Move:
9.63%
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.02. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $239.00. The Score for RMD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- RMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
RMD Stock Price Chart
CANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 36.28 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.08 - 2.36) | Sell |
Bollinger Bands (100): | (2.11 - 3.15) | Sell |
RMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.17 | Buy |
Relative Strength Index (14 RSI): | 48.53 | Sell |
Chaikin Money Flow: | -1050033 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (237.55 - 250.79) | Sell |
Bollinger Bands (100): | (200 - 236.14) | Buy |
CANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.04 | Sell |
20-day SMA: | 2.2 | Sell |
50-day SMA: | 2.59 | Sell |
200-day SMA: | 2.36 | Sell |
8-day EMA: | 2.07 | Sell |
20-day EMA: | 2.19 | Sell |
50-day EMA: | 2.41 | Sell |
200-day EMA: | 2.56 | Sell |
RMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 242.7 | Sell |
20-day SMA: | 246.18 | Sell |
50-day SMA: | 229.88 | Buy |
200-day SMA: | 201.27 | Buy |
8-day EMA: | 243.22 | Sell |
20-day EMA: | 242.45 | Sell |
50-day EMA: | 232.43 | Buy |
200-day EMA: | 208.09 | Buy |
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.19 per share, and an increase next year of $1.40 per share.
Can Fite Biofarma Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ResMed Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |